| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0733-8627(05)70170-X |
| P698 | PubMed publication ID | 11214393 |
| P2093 | author name string | Cunningham R | |
| Mikhail MG | |||
| P2860 | cites work | Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: Beneficial effect of an added beta adrenergic blocking agent | Q28317547 |
| Atrial fibrillation as an independent risk factor for stroke: the Framingham Study | Q29614200 | ||
| Evaluation and management of the patient with syncope | Q33150067 | ||
| Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin | Q33153852 | ||
| Syncope: current diagnostic evaluation and management | Q33160405 | ||
| Psychiatric syncope: a new look at an old disease. | Q33162229 | ||
| The head-up tilt table test in patients with syncope of unknown origin | Q33168228 | ||
| A prospective evaluation and follow-up of patients with syncope | Q33172994 | ||
| Diagnosing syncope. Part 1: Value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians | Q33175214 | ||
| Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin | Q33610685 | ||
| Functional capacity before and after cardioversion of atrial fibrillation: a controlled study | Q33614001 | ||
| Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study | Q34054106 | ||
| Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). | Q34060107 | ||
| Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm | Q34117347 | ||
| The natural history of lone atrial fibrillation. A population-based study over three decades | Q34186025 | ||
| Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study | Q34186228 | ||
| Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study | Q34201000 | ||
| Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats | Q34721297 | ||
| Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study | Q34727157 | ||
| Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter | Q35902898 | ||
| Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy | Q37207412 | ||
| Digoxin for atrial fibrillation: a drug whose time has gone? | Q37654747 | ||
| Cardioversion of atrial fibrillation | Q38640147 | ||
| Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group | Q39278247 | ||
| Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent? | Q39733729 | ||
| Effects of digitalis on the normal and the failing heart | Q39818351 | ||
| Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association | Q41000819 | ||
| Current recommendations for the anticoagulation of patients with atrial fibrillation. | Q41023258 | ||
| Transesophageal echocardiography-guided approach to cardioversion of atrial fibrillation | Q41023264 | ||
| Risk of thromboembolism in new onset or transient atrial fibrillation | Q41023284 | ||
| The medical management of atrial fibrillation. | Q41664554 | ||
| Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation | Q41989836 | ||
| Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation | Q43419712 | ||
| Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography | Q43769453 | ||
| Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm | Q43782586 | ||
| Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter | Q43787981 | ||
| Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial | Q43969736 | ||
| Direct current cardioversion of established atrial fibrillation | Q44015191 | ||
| Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia | Q45038588 | ||
| Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation | Q46112213 | ||
| Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation | Q46213915 | ||
| Atrial fibrillation with left atrial spontaneous contrast detected by transesophageal echocardiography is a potent risk factor for stroke | Q48942997 | ||
| The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study | Q50542101 | ||
| Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. | Q51004375 | ||
| Left atrial spontaneous contrast echoes--markers of thromboembolic risk in patients with atrial fibrillation. | Q51060900 | ||
| Cardioembolic stroke. | Q52307946 | ||
| Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. | Q52342463 | ||
| Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. | Q54262419 | ||
| Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy | Q67554308 | ||
| Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators | Q67716302 | ||
| Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators | Q67716321 | ||
| Left atrial spontaneous echo contrast: A clinical and echocardiographic analysis | Q67921185 | ||
| Magnitude of ST segment depression during paroxysmal supraventricular tachycardia | Q68058037 | ||
| Asymptomatic cerebral infarction in patients with chronic atrial fibrillation | Q68459675 | ||
| Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm | Q68495464 | ||
| Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation | Q68498046 | ||
| Nonvalvular atrial fibrillation as a cause of fatal massive cerebral infarction in the elderly | Q69400932 | ||
| Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusion | Q69688177 | ||
| Atrial fibrillation and mortality in an elderly population | Q69744633 | ||
| The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation | Q69801094 | ||
| Anticoagulation for cardioversion of atrial fibrillation | Q69959711 | ||
| The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation | Q70105143 | ||
| Hemodynamic effects of cardioversion in chronic atrial fibrillation. Special reference to coronary artery disease | Q70348922 | ||
| Cardioversion of atrial fibrillation: consideration of embolization, anticoagulation, prophylactic pacemaker, and long-term success | Q70443039 | ||
| Pronounced ST-segment depression during paroxysmal supraventricular tachycardia | Q70509110 | ||
| Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi | Q70570906 | ||
| Echocardiographic findings associated with atrial fibrillation in 1,699 patients aged > 60 years | Q71551159 | ||
| Clinical course of acute atrial fibrillation treated with rapid digitalization | Q71657363 | ||
| Coronary heart disease and atrial fibrillation: the Framingham Study | Q71782665 | ||
| The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study | Q72198409 | ||
| Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter | Q72226782 | ||
| Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation | Q72248451 | ||
| Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation | Q72360980 | ||
| Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study | Q72429317 | ||
| Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation | Q72468018 | ||
| Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study | Q72523256 | ||
| Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications | Q72566134 | ||
| Usefulness of transesophageal echocardiography to screen for left atrial thrombus before elective cardioversion for atrial fibrillation | Q72646585 | ||
| Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications | Q72740780 | ||
| Clinical implications and factors related to left atrial spontaneous echo contrast in chronic nonvalvular atrial fibrillation | Q72790205 | ||
| Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease | Q72906519 | ||
| Risk stratification of patients with syncope | Q73205799 | ||
| Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours | Q73223936 | ||
| Value of ST-segment depression during paroxysmal supraventricular tachycardia in the diagnosis of coronary artery disease | Q74595402 | ||
| Evaluation and management of atrial fibrillation in the emergency department | Q74632322 | ||
| P433 | issue | 1 | |
| P921 | main subject | syncope | Q180007 |
| heart arrhythmia | Q189331 | ||
| P304 | page(s) | 105-21, vii | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Emergency medicine clinics of North America | Q26842347 |
| P1476 | title | Management of patients with syncope and cardiac arrhythmias in an emergency department observation unit | |
| P478 | volume | 19 |
Search more.